The suspension is in response to the outcomes of its post Emergency Use Authorisation inspection held between March 14-22, WHO said
03 Apr 2022 1:07 PM
The trials will be done at 9 different sites, with sources adding that the intranasal vaccine is likely to be launched by March
28 Jan 2022 2:22 PM
The SEC has asked the Hyderabad-based vaccine manufacturer to submit its revised protocol for trials
05 Jan 2022 1:15 PM
The World Health Organisation on Wednesday granted approval for Emergency Use Listing Covaxin
06 Nov 2021 11:10 AM
CDSCO has approved the extension of shelf life of Covaxin up to 12 months from the date of manufacture
03 Nov 2021 11:49 PM
Currently, Covaxin has a shelf life of 6 months with subject to its storage at 2-8 degrees celsius
03 Nov 2021 3:52 PM
All passengers who have received two doses of Covaxin atleast 14 days before the estimated arrival date can travel to Oman
28 Oct 2021 12:28 PM
Ocugen has already sought regulatory approval from Health Canada for Covaxin to be used in that country
27 Oct 2021 7:04 PM
The clarifications are sought to conduct a final 'risk-benefit assessment' for Emergency Use Listing of the vaccine
27 Oct 2021 8:06 AM
Hyderabad-based Bharat Biotech had submitted Expression of Interest on April 19 for its vaccine
18 Oct 2021 1:00 PM
The two-dose vaccine will be administered with a gap of 28 days
14 Oct 2021 7:26 AM
The vaccine manufacturer had completed the Phase 2/3 trials of Covaxin for use in children under 18 years of age in mid-September
12 Oct 2021 1:42 PM
The duration of the emergency use listing process depends on the quality of the data which is submitted by the vaccine manufacturer
30 Sep 2021 1:22 PM
On the production levels of Covaxin, Ella said 100 million doses per month can be possible
21 Sep 2021 2:24 PM
Rolling data allows the WHO to start its review right away, as information continues to come in, to accelerate the overall review process
17 Sep 2021 2:31 PM
India’s vaccine chain has to protect against contamination before vaccines arrive, using tamper-proof seals and a transparent supply chain
30 Aug 2021 9:57 PM
The 5 vaccines granted EUA in India are SI's Covishield, Bharat Biotech's Covaxin, Russia's Sputnik V, Moderna and now Johnson & Johnson
07 Aug 2021 2:37 PM
Termination of the MoU came after the deal with the Brazilian Government for supply of 20 million doses of Covaxin landed in controversy
27 Jul 2021 10:28 AM
The government had been counting on deliveries of 60 million to 70 million Covaxin doses monthly from July or August
27 Jul 2021 6:53 AM
Bharat Biotech had on Friday announced cancellation of the MoU it signed for its COVID-19 vaccine Covaxin for the Brazilian market
24 Jul 2021 11:44 AM